The dilemmas of borderline epithelial lesions of the breast;Les dilemmes des lesions frontieres

Reproduction Humaine et Hormones

Volumn 12, Issue 5, 1999, Pages 439-450

  Espié, Marc ^a   De Roquancourt, Anne ^a   Perret, Francine ^a   Gorins, André ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Atypical hyperplasia; Bordeline epithelial lesions of the breast; Fibroadenoma; Sclerosing adenosis

Indexed keywords

BREAST CANCER; BREAST FIBROADENOMA; BREAST LESION; EPITHELIUM HYPERPLASIA; GENE EXPRESSION; HETEROZYGOSITY; ONCOGENE NEU; PROGNOSIS; REVIEW; TUMOR GROWTH;

EID: 0032790631     PISSN: 09943919     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. ALLRED D. C., CLARK M., MOLINA R., ATUL K., TANDON A. K., SCHNITT S. J., GILCHRIST K. W., OSBORNE C. K., TORMEY D. C., MCGUIRE W. L. - Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progession of in situ to invasive breast cancer. Human Parhol, 1992, 23, 974-979.
2. BAGHURST P. A., ROHAN T. E. : Dietary fiber and risk of benign proliferative epithelial disorders of the breast. Int J Cancer, 1995, 481-485.
3. BARTEK J., BARTKOVA J., VOJTESEK B., STASKOVA Z., REJTHAR A., KOVARIK J., LANE D.P. : Patterns of expression of the p53 tumor suppressor in human breast tissues and tumors in situ and in vitro. Int J Cancer, 1990, 46, 839-844.
4. BARTOW S. A., PATHAK D. R., BLACK W. C. - Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer: a forensic autopsy study. Cancer, 1987, 60, 2751-2760.
5. BERKOWITZ G. S., CANNY P. F., VIVOLSI V. A., MERINO M. J., O'CONNOR T. Z., KELSEY J.L. - Cigarette smoking and benign breast disease. J Epidemiol Community Health, 1985, 39, 308-313.
6. BERKOWITZ G. S., KELSEY J. L., HOLFORD T. R., LIVOLSI V. A., MERINO M. J., BECK G. J., ORT S., O'CONNOR T. Z., WHITE C. - Estrogen replacement therapy and fibrocystic breast disease in post-menopausal women. Am J Epidemiol, 1985, 121, 238-245.
7. BERKOWITZ G. S., KELSEY J. L., LIVOLSI V. A. - Exogenous hormone use and fibrocystic breast disease by histopathologic component. Int J Cancer, 1984, 34, 443-449.
8. BODIAN C. A., PERZIN K. H., LATTES R., HOFFMANN P. - Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications. Cancer, 1993, 71, 3908-3913.
9. BODIAN C. A., PERZIN K. H., LATTES R., HOFFMANN P., ABERNATHY T. G. - Prognostic significance of benign proliferative breast disease. Cancer, 1993, 71, 3896-3907.
10. BOYD N. F., BYNG J. W., JONG R. A., FISHELL E. K., LITTLE L. E., MILLER A. B., LOCKWOOD G. A., TRITCHLER D. L., YAFFE M. J. - Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst, 1995, 87, 670-675.
11. BRINTON L. A., VESSEY M. P., FLAVEL R., YEATES D. - Risk factors for benign breast disease. Am J Epidemiol 1981, 113, 203-214.
12. CARTER C. L., CORLE D. K., MICOZZI M. S. - Prospective study of the developpement of breast cancer in 16, 692 women with benign breast disease. Am J Epidemiol 1988, 128, 467-477.
13. CARTER D. - Intraductal papillary tumors of the breast. Cancer, 1977, 39, 1689-1692.
14. CHAN H. P., DOI K., METZ C. E., LAM K. L., SCHMIDT R. A. - Feature-extraction technics for a computer aided system for detection of microcalcifications in digital mammograms. Med Phys, 1987, 14, 493.
15. CHRISTOV K., CHEW K. L., LJUNG B. M., WALDMAN F. M., GOODSON I. W. H., SMITH H. S., MAYAL B. H. - Cell proliferation in hyperplastic and in situ carcinoma lesions of the breast estimated by in vivo labeling with bromodeoxyuridine. J Cell Biochem, 1994, 19 (suppl), 165-172.
16. CHUAQUI R. F., ZHUANG Z., EMMERT-BUCK M. R., LIOTTA L. A., MERINO M. J. - Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast. Am J Pathol. 1997, 150, 297-303.
17. CIATTO S., BONARDI R., ZAPPA M., GIORGI D. - Risk of breast cancer subsequent to histological or clinical diagnosis of fibroadenoma - retrospective longitudinal study of 3938 cases. Ann Oncol, 1997, 8, 297-300.
18. COLE P., ELWOOD J. M., KAPLAN S. D. - Incidence rates and risk factors of benign breast neoplasms. Am J Epidemiol. 1978, 108, 112-120.
19. er Journées Chirurgicales de l'Institut Gustave Roussy, 1985 (décembre).
20. CRISSMAN J. D., VISSCHER D. W., KUBUS J. - Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Arch Pathol Lab Med, 1990, 114, 1249-1253.
21. DAHLSTROM J. E., SUTTON S., JAIN S. - Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions. Hystolpathology, 1996, 28, 537-541.
22. DIAZ N. M., PALMER J. O., MCDIVITT R. W. - Carcinoma arising within fibroadenomas of the breast. Am J Clin Pathol, 1991, 95, 614-622.
23. DUFFY S. W., ROBERTS M. M., ELTON R. A. - Risk factors relevant to cystic breast disease: a case-control study. J Epidemiol Community Health, 1983, 37, 271-273.
24. DUPONT W., PARL F. F., HARTMANN W. H., BRINTON L. A., WINFIELD A. C., WORRELL J. A., SCHUYLER P. A., PLUMMER W. D. - Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer, 1993, 71, 1258-1265.
25. DUPONT W. D., PAGE D. L. - Relative risk of breast cancer varies with time since diagnosis of atypical hyperplasia. Human Pathol, 1989, 20, 723-725.
26. DUPONT W. D., PAGE D. L. - Risk factors for breast cancer in women with proliferative breast disease. N. Engl. J. Med., 1985, 312, 146-151.
27. DUPONT W. D., PAGE D. L., PARL F. F., VNENCAK-JONES C. L., PLUMMER W. D., RADOS M. S., SCHUYLER P. A. - Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med, 1994, 331, 10-15.
28. DUPONT W. D., PAGE D. L., ROGERS L., PARL F. F. - Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer, 1989, 63, 948-957.
29. ERIKSSON E. T., SCHIMMELPENNING H., ASPENBLAD U., ZETTERBERG A., AUER G. A, - Immunohistochemical expression of the mutant p53 protein and nuclear DNA content during the transition from benign to mlignant breast disease. Human Parhol, 1994, 25, 1228-1233.
30. ERNSTER V. L., GOODSON W. H. I., HUNT T. K., PETRAKIS N. L., SICKLERS E. A., MIIKE R. - Vitamin E and benign breast "disease": a double-blind, randomized clinical trial. Surgery, 1985, 97, 490-494.
31. GIRI D. D., DUNDAS S. A. C., NOTTINGHAM J. F., UNDERWOOD J. C. E. : Oestrogen receptors in benign epithelial lesions and intraductal carcinomas of the breast: an immunohistological study. Histopathology, 1989, 15, 575-584.
32. GOEHRING C., MORABIA A. : Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev, 1997, 19, 310-327.
33. GORINS A., DILHUYDY M. H., PETIT J. Y., CONTESSO G. - Quand faut-il opérer une mastopathie à risque ? Le point de vue du clinicien. Rev Fr Gynecol Obstet, 1991, 86, 15-20.
34. HALL P. A., RAY A., LEMOINE N. R., MIDGLEY C. A., KRAUSZ T., LANE D. P. - p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet, 1991, 338, 513.
35. HELVIE M. A., HESSLER C., FRANK T. S., IKEDA D. M. - Atypical hyperplasia of the breast: mammographic appearance and histologic correlation. Radiology, 1991, 179, 759-764.
36. HSIEH C. C., CROSSON A. W., WALKER A. M. - Oral contraceptive use and fibrocystic breast disease of different histologic classifications. J Natl Cancer Inst, 1984, 72, 285-290.
37. HSIEH C. C., WALKER A. M., TRAPIDO E. J. : Age at first birth and breast atypia. Int J Cancer, 1984, 33, 309-312.
38. INGRAM D. M., NITTAGE E., ROBERTS T. : The role of diet in the development of breast cancer: a case-control study of patients with breast cancer, benign epithelial hyperplasia, and fibrocystic disease of the breast. Br J Cancer, 1991, 64, 187-191.
39. JACKMAN R. J., NOWELS K. W., SHEPARD M. J., FINDELSTEIN S. I., MARZONI F. A. : Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology, 1994, 193, 91-95.
40. JACOBS T. W., BYRNE C., COLDITZ G., CONNOLLY J. L., SCHNITT S. J. - Radial scars in benign breast-biopsy specimens and the risk of breast cancer. N Eng J Med, 1999, 340, 430-436.
41. JACQUEMIER J., GANDILHON P. H., CHARPIN C., POURREAU-SCHEIDER N., HASSOUN J., MARTIN P. M. : Tissu mammaire - récepteurs oestrogéniques, analyse immunohistochimique et biochimique du tissu normal, hyperplasique et du carcinome in-situ. Bull Cancer, 1987, 74, 129-149.
42. JENSEN R. A., PAGE D. L., DUPONT W. D., ROGERS L. W. : Invasive breast cancer risk in women with sclerosing adenosis. Cancer, 1989, 1977-1989.
43. JICK S. S., WALKER A. M., JICK H. : Conjugated estrogens and fibrocystic breast disease. Am J Epidemiol, 1986, 124, 746-751.
44. KING E. B., CHEW K. L., HOM J. D., DUARTE L., MAYALL B., MILLER T. R., NEUHAUS J. M., WRENSCH M. R., PETRAKIS N. L. : Characterization by image cytometry of duct epithelial proliferative disease of the breast. Mod Pathol, 1991, 4, 291-296.
45. KRAMER W. N., RUSH Jr B. F. : Mammary duct prolifération in the elderly. A histopathologic study. Cancer, 1973, 31, 130-137.
46. LAKHANI S., SLACK D., HAMOUDI R., COLLINS N., STRATTON M., SLOANE J. : Detection of allelic imbalance indictes that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations. Lab Invest, 1996, 74, 129-135.
47. LAKHANI S. R., COLLINS N., STRATTON M. R., SLOANE J. P. : Atypical ductal hyperplasia of the breast: clonal proliferation exhibiting loss of heterozygosity on chromosome 16q and 17q. J Clin Pathol, 1995, 48, 611-615.
48. LE GALL M., DURAND J., LAURENT M., PELLIER D. : Conduite à tenir devant une mammographie révélatrice de microcalcifications groupées sans tumeur palpable. Nouv Presse Méd, 1976, 5, 1623-1627.
49. LEVI F., RANDIMBISON L., TE V.-C., LA VECCHIA C. : Incidence of breast cancer in women with fibroadenoma. Int J Cancer, 1994, 57, 681-683.
50. LIBERMAN L., COHEN M. A., DERSHAW D. D., ABRAMSON A. F., HANN L. E., ROSEN P. P. : Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR, 1995, 164, 111-1113.
51. LINELL F. : Precursors lesions of breast carcinoma. The Breast, 1993, 2, 220-223.
52. LIVOLSI V. A., STADEL B. V., KELSEY J. L. : Fibrocystic breast disease in oral-contraceptive users: a histopathological evaluation of epithelial atypia. N Engl J Med, 1978, 299, 381-385.
53. LODATO R. F., MAGUIRE JR H. C., GREENE M. I., WEINER D. B., LIVOLSI V. A. : Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical ductal hyperplasia of the breast. Mod Pathol, 1990, 3, 449-454.
54. LONDON R. S., SUNDARAM G. S., MURPHY L., MANIMEKALAI S., REYNOLDS M., GOLDSTEIN P. J. : The effect of vitamin E on mammary dysplasia: a double-blind study. Obstet Gynecol, 1985, 65, 104-106.
55. LONDON S. J., CONNOLLY J. L., SCHNITT S. J., COLDITZ G. A. : A prospective study of benign breast disease and the risk of breast cancer. JAMA, 1992, 267, 941-944.
56. LONDON S. J., STEIN E. A., HENDERSON I. C., STAMPFER M. J., WOOD W. C., REMINE S., DMOCHOWSKI J. R., ROBERT N. J., WILLETT W. C. : Carotenoids, retinol, and vitamin E and risk of proliferative benign breast disease and breast cancer. Cancer causes Control, 1992, 3, 503-512.
57. LUBIN F., RONE E., WAX Y. : A case-control study fo caffeine and methylxanthines in benign breast disease. JAMA, 1985, 253, 2388-2392.
58. LUBIN F., WAX Y., RON E. : Nutional factors associated with benign breast disease etiology: a case-control study. Am J Clin Nutr, 1989, 50, 551-556.
59. LUQMANI Y. A., CAMPBELL T., SOOMRO S., SHOUSHA S., RIO M. C., COOMBES R.C. : Immunohistochemical localisation of pS2 protein in ductal carcinoma in situ and benign lesions of the breast. Br J Cancer, 1993, 67, 749-753.
60. MA L., BOYD N. F. : Atypical hyperplasia and breast cancer risk: a critique. Cancer Causes Control, 1992, 3, 517-525.
61. MARSHALL L. M., HUNTER D. J., CONNOLLY J. L., SCHNITT S. J., BYRNE C., LONDON S. J., COLDITZ G. A. : Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev, 1997, 6, 297-301.
62. MCDIVITT R. W., STEVENS J. A., LEE N. C., WINGO P. A., RUBIN G. L., GERSELL D. : The Cancer and Steroid Hormone Study Group. Histologic types of benign breast disease and the risk for breast cancer. Cancer, 1992, 69, 1408-1414.
63. MOLLER P., MECHTERSHEIMER G., KAUFMANN M., MOLDENHAUER G., MOMBURG F., MATTFELDT T., OTTO H. F. : Expression of epidermal growth factor receptor in benign and malignant primary tumours of the breast. Virchows Archiv A Pathol Anat, 1989, 414, 157-164.
64. e journées de la Société Française de Sénologie et de Pathologie mammaire. Avignon. 1987.
65. MOORE M. M., HARGETT C. W., HANKS J. B., FAJARDO L. L., HARVEY J. A., FRIERSON H. F., SLINGLUFF C. L. : Association of breast cancer with the finding of atypical ductal hyperplasia at core breast biopsy. Ann Surg, 1997, 225, 726-733.
66. NIELSEN M., JENSEN J., ANDERSEN J. : Precancerous and cancerous breast lesions during lifetime and at autopsy: a study of 83 women. Cancer, 1984, 54, 612-615.
67. NIELSON M., THOMSEN J. L., PRIMDAHL S. : Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer, 1987, 56, 814-819.
68. NORRIS H. J., BAHR G., MIKEL U. V. : A comparative morphometric and cytophotometric study of intraductal hyperplasia and intraductal carcinoma of the breast. Annal Quant Cytol Histol, 1988, 10, 1-9.
69. PAGE D., ANDERSON T., ROGERS L. : Epithelial hyperplasia. in Diagnostic histopathology of the breast, Churchill Livingstone Ed, Edinburgh 1987, pp. 120-156
70. PAGE D. L., DUPONT W. D., ROGERS L. W., RADOS M. S. : Atypical hyperplastic lesions of the female breast : a long-term follow-up study. Cancer, 1985, 55, 2698-2708.
71. PAGE D. L., SALHANY K. E., JENSEN R. A., DUPONT W. D. : Subsequent breast cancer risk after biopsy with atypia in a breast papilloma. Cancer, 1996, 78, 258-266.
72. PALLI D., ROSSELLI DEL TURCO M., SIMONCINI R., BIANCHI S. : Benign breast disease and breast cancer : a case-control study in a cohort in Italy. Int J Cancer, 1991, 47, 703-706.
73. PARAZZINI F., FERRARONI M., LA VECCHIA C., BARON J. A., LEVI F., FRANCESCHI S., DECARLI A. : Smoking habits and risk of benign breast disease. Int J Epidemiol, 1991, 20, 430-434.
74. PASTIDES H., KELSEY J. L., LI VOLSI V. A. : Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology. J Natl Cancer, 1983, 22, 700-707.
75. PASTIDES H., KELSEY J. R., HOLFORD T. R., LIVOLSI V. A. : An epidemiologic study of fibrocystic breast disease with reference to ductal epithelial hyperplasia. Am J Epidemiol, 1985, 121, 440-447.
76. PICK P. W., IOSSIFIDES I. A. : Occurrence of breast carcinoma within a fibroadenoma. Arch Pathol Lab Med, 1984, 108, 590-594.
77. RAVNIHAR B., SEIGEL D. G., LINDTNER J. : An epidemiologic study of breast cancer and benign breast neoplasias in relation to oral contraceptive and estrogen use. Eur J Cancer, 1979, 15, 395-405.
78. ROMAN T. E., COOK M. G. : Alcohol consumption and risk of benign proliferative epithalial disorders of the breast in women. Int J Cancer, 1989, 43, 631-636.
79. ROMAN T. E., COOK M. G., BARON J. A. : Cigarette smoking and benign proliferative epithelial disorders of the breast in women: a case-control study. J Epidemiol Community Health, 1989, 43, 362-368.
80. ROHAN T. E., COOK M. G., MC MICHAEL A. J. : Methylxantines and benign proliferative epithelial disorders of the breast in women. Int J Epidemiol, 1989, 18, 626-633.
81. ROHAN T. E., COOK M. G., POTTER J. D. : A case-control study of diet and benign proliferative epithelial disorders of the breast. Cancer Res, 1990, 50, 3176-3181.
82. ROHAN T. E., HARTWICK W., MILLER A. B., KANDEL R. A. : Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk. J Natl Cancer Inst, 1998, 90, 1262-1269.
83. ROSENBERG C. L., LARSON P. S., ROMO J. D., DE LAS MORENAS A., FALLER D. V. : Microsatellite alterations indicating monoclonality in atypical hyperplasias associated with breast cancer. Human Pathol, 1997, 28, 214-219.
84. RUBIN E., MAZUR M. T., URIST M. M., MADDOX W. A. : Clinical, radiographic and pathologic correlation of atypical hyperplasia, ductal carcinoma in situ, and ductal carcinoma in situ with microinvasion. The Breast, 1993, 2, 21-26.
85. RUBIN E., VISSCHER D. W., ALEXANDER R. W., URIST M. M., MADDOX W. A. : Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically. Cancer, 1988, 61, 2077-2082.
86. TAVASSOLI F. A. : Intraductal hyperplasias. ordinary and atypical, in Pathology of the breast. Appleton & Lange Ed. Norwalk Connecticut 1992, pp. 155-191
87. TOKUNAGA M., LAND C. E., AOKI Y., YAMAMOTO T., ASANO M., SATO E., TOKUOKA S., SAKAMOTO G., PAGE D. L. : Proliferative and non-proliferative breast disease in atomic brom survivors. Cancer, 1993, 72, 1657-1664.
88. VAN AGTHOVEN T., TIMMERMANS M., FOEKENS J. A., DORSSERS C. J., HENZEN-LOGMAN S. C. : Differential expression of estrogen. progesterone, and epidermal growth factor receptors in normal, benign, and malignant human breast tissues using dual staining immunohistochemistry. Am J Pathol, 1994, 144, 1238-1246.
89. VOBECKY J., SIMARD A., VOBECKY J. S., GHADIRIAN P., LAMOTHE-GUAY M., FALARDEAU M. : Nutritional profile of women with fibrocystic breast disease. Int J Epidemiol, 1993, 22, 989-999.
90. WOLFE J. N. : Risk for breast cancer developpement determined by mammographic parenchymal pattern. Cancer, 1976, 37, 2486-2492.
91. YOUNES M., LEBOVITZ R. M., BOOMER K. E., CAGLE P. T., MORTON D., KHAN S., LAUCIRICA R. : p53 accumulation in benign breast biopsy specimens. Human Pathol, 1995, 26, 155-158.
92. YU H., ROHAN T. E., COOK M. G., HOWE G. R., MILLER A. B. : Risk factors for fibroadenoma: a case-control study in Australia. Am J Epidemiol, 1992, 135, 247-258.